Developer:
Monsanto Company (including fully and partly owned companies)

Method of Trait Introduction:
Agrobacterium tumefaciens-mediated plant transformation

GM Trait s :
Delayed ripening/senescence , Antibiotic resistance

Commercial Trait:
(Singular)  Modified Product Quality

Summary of Basic Genetic Modification

Gene Introduced	Gene Source	Product	Function
accd	Pseudomonas chlororaphis	1-amino-cyclopropane-1-carboxylic acid deaminase enzyme	metabolizes the precursor of the fruit ripening hormone ethylene, resulting in delayed fruit ripening
nptII  *	Escherichia coli Tn5 transposon	neomycin phosphotransferase II enzyme	allows transformed plants to metabolize neomycin and kanamycin antibiotics during selection

 * : Selection Marker/Reporter  

Summary of Regulatory Approvals: Country, Year and Type of Approval

Country	Food direct use or processing	Feed direct use or processing	Cultivation domestic or non-domestic use
United States

 

Event Description

• CBD Biosafety Clearing House
• CERA GM Crop Database

Regulatory and Biosafety Information

• US Department of Agriculture - APHIS
• US Food and Drug Administration

Detection Methods

• GMO Detection Method Database